Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-26 Sale | 2023-09-28 4:32 pm | REATA PHARMACEUTICALS INC | RETA | Desai Antal Rohit CPMG Inc Director 10% Owner | 2,928,368 | $0 | $0 | 0 (Indirect) | View |
| 2023-09-26 Sale | 2023-09-26 7:18 pm | REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner | 2,926,776 | $0 | $0 | 0 (Indirect Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 49,701 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director | 5,565 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 28,416 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 62,621 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Director | 599,583 | $0 | $0 | 0 (Indirect Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 7,359 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 81,633 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 33,805 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Patni Rajiv EVP, Chief R&D Officer | 45,000 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Ryder Steven Director | 10,907 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 132,878 | $0 | $0 | 0 (Indirect Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director | 6,116 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 6,017 | $0 | $0 | 0 (Direct) | View |
| 2023-09-26 Sale | 2023-09-26 4:30 pm | REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer | 24,089 | $0 | $0 | 0 (Direct) | View |
| 2023-09-14 Sale | 2023-09-18 5:34 pm | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 3,175 | $172.03 | $546,181 | 28,416 (Direct) | View |
| 2023-09-05 Sale | 2023-09-07 4:11 pm | REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer | 406 | $169.2 | $68,695 | 24,089 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 4:46 pm | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 1,205 | $168.95 | $203,581 | 49,701 (Direct) | View |
| 2023-08-16 Sale | 2023-08-17 4:43 pm | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 1,755 | $168.41 | $295,566 | 62,621 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 4:40 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 2,740 | $169 | $463,052 | 81,633 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 4:35 pm | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 1,205 | $168.8 | $203,409 | 33,805 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 4:31 pm | REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer | 403 | $168.72 | $67,995 | 24,495 (Direct) | View |
| 2023-07-28 Sale | 2023-08-01 4:47 pm | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 75,000 | $164.62 | $12,346,298 | 314,376 (Direct) | View |
| 2023-07-28 Sale | 2023-08-01 4:41 pm | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 8,235 | $164.53 | $1,354,887 | 10,693 (Direct) | View |
| 2023-07-28 Sale | 2023-08-01 4:35 pm | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 5,000 | $164.49 | $822,442 | 15,517 (Direct) | View |
| 2023-07-28 Sale | 2023-08-01 4:29 pm | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 40,000 | $164.54 | $6,581,428 | 75,010 (Direct) | View |
| 2023-06-14 Sale | 2023-06-16 4:03 pm | REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer | 2,343 | $102.11 | $239,248 | 48,336 (Direct) | View |
| 2023-06-12 Sale | 2023-06-14 4:35 pm | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 82,796 | $102.71 | $8,503,640 | 133,376 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-15 Gift | 2023-09-19 4:30 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Director | 232,000 | $0 | 9,260,094 (Indirect) | View |
| 2023-08-23 Gift | 2023-08-24 4:41 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Director | 500,000 | $0 | 599,583 (Indirect) | View |
Ownership | 2023-08-07 5:18 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | BIOGEN INC. See footnotes | 0 | $0 | 0 (Indirect) | View |
| 2023-07-28 Exercise | 2023-08-01 4:47 pm | N/A 2029-08-28 | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 75,000 | $0 | 314,376 (Direct) | View |
| 2023-07-28 Exercise | 2023-08-01 4:47 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 75,000 | $72.7 | 314,376 (Direct) | View |
| 2023-07-28 Conversion | 2023-08-01 4:47 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 75,000 | $0 | 314,376 (Direct) | View |
| 2023-07-28 Exercise | 2023-08-01 4:41 pm | N/A 2031-04-15 | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 8,235 | $0 | 10,693 (Direct) | View |
| 2023-07-28 Exercise | 2023-08-01 4:41 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 8,235 | $92.2 | 10,693 (Direct) | View |
| 2023-07-28 Exercise | 2023-08-01 4:35 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 5,000 | $26.46 | 15,517 (Direct) | View |
| 2023-07-28 Exercise | 2023-08-01 4:35 pm | N/A 2027-03-01 | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 5,000 | $0 | 15,517 (Direct) | View |
| 2023-07-28 Conversion | 2023-08-01 4:35 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 5,000 | $0 | 15,517 (Direct) | View |
| 2023-07-28 Exercise | 2023-08-01 4:29 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 40,000 | $22.57 | 75,010 (Direct) | View |
| 2023-07-28 Exercise | 2023-08-01 4:29 pm | N/A 2026-12-07 | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 40,000 | $0 | 75,010 (Direct) | View |
| 2023-07-28 Conversion | 2023-08-01 4:29 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 40,000 | $0 | 75,010 (Direct) | View |
| 2023-07-06 Option Award | 2023-07-10 4:49 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 4,125 | $0 | 50,906 (Direct) | View |
| 2023-07-06 Option Award | 2023-07-10 4:47 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 6,000 | $0 | 64,376 (Direct) | View |
| 2023-07-06 Option Award | 2023-07-10 4:45 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 6,000 | $0 | 84,373 (Direct) | View |
| 2023-07-06 Option Award | 2023-07-10 4:42 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 4,125 | $0 | 35,010 (Direct) | View |
| 2023-07-06 Option Award | 2023-07-10 4:38 pm | N/A 2032-09-29 | REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer | 359,656 | $0 | 1,203,010 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 4:03 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer | 1,562 | $0 | 48,336 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 4:03 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer | 1,562 | $27.32 | 48,336 (Direct) | View |
| 2023-06-13 Exercise | 2023-06-14 4:35 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 25,000 | $0 | 133,376 (Direct) | View |
| 2023-06-13 Exercise | 2023-06-14 4:35 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President | 25,000 | $27.32 | 133,376 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 4:26 pm | N/A 2033-06-12 | REATA PHARMACEUTICALS INC | RETA | Patni Rajiv EVP, Chief R&D Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 5:00 pm | N/A 2033-06-07 | REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Member of 10% owner group Director 10% Owner | 4,275 | $0 | 5,360 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 5:00 pm | N/A 2033-06-07 | REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Member of 10% owner group Director 10% Owner | 1,085 | $73.68 | 5,360 (Direct) | View |